LIQUIDIA CORPORATION

LQDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jul 2026 Jun 2026 May 2026 Mar 2026 Feb 2026 Dec 2025 Oct 2025 Sep 2025
Revenue $171.7M $132.9M $54.3M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $17.2M $12.6M $9.3M
SG&A Expense $57.4M $46.9M $40.1M
Operating Income $85.5M $61.5M $1.8M
Operating Margin 49.8% 46.3% 3.3%
Interest Expense
Pretax Income $81.7M $56.8M
Income Tax Expense $7.0M $3.9M
Net Income $74.7M $52.9M $-3.5M
Net Margin 43.5% 39.8% -6.5%
EPS (Basic) $0.84 $0.60 $-0.04
EPS (Diluted) $0.74 $0.52 $-0.04
Shares Outstanding (Basic) 89.5M 88.9M 88.9M 88.0M 88.1M 87.2M 87.0M 86.3M
Shares Outstanding (Diluted) 89.5M 101.4M 88.9M 101.1M 88.1M 87.2M 87.0M 86.3M
Dividends Per Share
← Newer Page 1 of 7 Older →